Výsledky vyhledávání - "Naoya Sekiguchi"

Methotrexate-associated Hodgkin Lymphoma in a Patient with Rheumatoid Arthritis Successfully Treated with Brentuximab Vedotin in Combination with Doxorubicin, Vinblastine, and Dacarbazine (BV+AVD)

Autor: Tadaaki Inano, Sakura Sakajiri, Keiji Sugimoto, Hiroko Iizuka, Shigeki Tomita, Masaaki Noguchi, Yasuharu Hamano, Tomohiro Sawada, Yasutaka Fukuda, Syuichi Shirane, Haruko Takizawa, Yasunobu Sekiguchi, Naoya Sekiguchi, Noriko Nakamura, Mitsuo Okubo, Hiroshi Izumi

Publikováno v: Internal medicine (Tokyo, Japan). 59(17)

A 53-year-old woman had been diagnosed with rheumatoid arthritis (RA) in X-6. She was started on methotrexate (MTX) in X-1. She developed a cough, and chest computed tomography showed abnormalities. In X, MTX was discontinued, but the cough persisted

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ebf50c2c0490c8e55ec315ddb9e70be
https://pubmed.ncbi.nlm.nih.gov/32461524

Zobrazit plný text záznamu

Securely collecting multidimensional health information from patients with rheumatoid arthritis using smart device technology: Beneficial effect for physicians and patients

Autor: Takuya Hirai, Mayumi Inoue, Keigo Ikeda, Takaaki Komatsu, Kana Tanji, Naoto Tamura, Kenji Takamori, Masayuki Takasago, Shinji Morimoto, Ken Yamaji, Atsuko Zushi, Iwao Sekigawa, Naoya Sekiguchi

Publikováno v: Musculoskeletal care. 16(4)

Aim A challenge to the medical care of patients with rheumatoid arthritis (RA) is the management of the wide variety of information, including medication history and disease status, obtained from multiple sources to inform treatment decisions. To add

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3135b9ba3425ecae088a5cd8dfc4a8a5
https://pubmed.ncbi.nlm.nih.gov/29956446

Zobrazit plný text záznamu

Plný text ve formátu HTML

Differences between the Health Assessment Questionnaire Disability Index (HAQ-DI) and the modified HAQ (mHAQ) score before and after infliximab treatment in patients with rheumatoid arthritis

Autor: Hayato Nagasawa, Naoya Sekiguchi, Tsutomu Takeuchi, Koichi Amano, Hideto Kameda

Publikováno v: Modern Rheumatology. 20:337-342

We conducted a 1-year prospective study to clarify differences between the Health Assessment Questionnaire disability index (HAQ-DI) and the modified HAQ (mHAQ) score among rheumatoid arthritis (RA) patients treated with infliximab. A total of 87 pat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1cc04b590848d7192cbd24f0a5f08a0b
https://doi.org/10.1007/s10165-010-0284-8

Zobrazit plný text záznamu

Improvement of the HAQ score by infliximab treatment in patients with RA: its association with disease activity and joint destruction

Autor: Hideto Kameda, Tsutomu Takeuchi, Hayato Nagasawa, Naoya Sekiguchi, Kouichi Amano

Publikováno v: Modern Rheumatology. 19:166-172

We conducted a two-year prospective study to clarify the efficacy of infliximab at improving the health assessment questionnaire (HAQ) score and associated factors in 67 patients with advanced rheumatoid arthritis (RA). All patients were scheduled to

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4feb1e3fd0b15631534a6969cc9010ae
https://doi.org/10.3109/s10165-008-0142-0

Zobrazit plný text záznamu

Notable Difference between the Development of Vertebral Fracture and Osteonecrosis of the Femoral Head in Patients Treated with High-dose Glucocorticoids for Systemic Rheumatic Diseases

Autor: Hirofumi Takei, Hiroe Ogawa, Tsutomu Takeuchi, Katsuya Suzuki, Hayato Nagasawa, Hideto Kameda, Koichi Amano, Naoya Sekiguchi

Publikováno v: Internal Medicine. 48:1931-1938

Vertebral fracture (VF) and osteonecrosis of the femoral head (OFH) are serious concerns in patients with rheumatic diseases treated with high-dose glucocorticoids (GCs). We comparatively examined the risk factors of VF and OFH in patients who had re

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c281ef779d7adf324b08c72dd1debb10
https://doi.org/10.2169/internalmedicine.48.2414

Zobrazit plný text záznamu

Retrospective clinical study on the notable efficacy and related factors of infliximab therapy in a rheumatoid arthritis management group in Japan: one-year outcome of joint destruction (RECONFIRM-2J)

Autor: Tsutomu Takeuchi, Yoshiya Tanaka, Naoya Sekiguchi, Kazuyoshi Saito, Eri Sato, Hisashi Yamanaka, Hideto Kameda, Shigeru Iwata, Eisuke Inoue, Hayato Nagasawa, Kouichi Amano, Katsunori Ikari, Masao Nawata, Takeshi Mochizuki

Publikováno v: Modern Rheumatology. 18:447-454

The anti-TNF-a chimeric monoclonal antibody infliximab is the first biologic to be approved for rheuma- toid arthritis (RA) in Japan, and post-marketing surveillance of all of the Japanese cases treated with infliximab has been conducted to explore t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::155edddbfaaf604e6e2daf525f1fd671
https://doi.org/10.3109/s10165-008-0077-5

Zobrazit plný text záznamu

Severe degenerative change of multiple organs mediated by chronic active Epstein–Barr virus infection with infected T-cell expansion

Autor: Norihide Sato, Shinji Itoyama, Atsushi Iizuka, Kyoko Hanzawa, Shigehisa Mori, Michihide Tokuhira, Jun-ichi Tamaru, Tsutomu Takeuchi, Yasunobu Sekiguchi, Hiroshi Suzuki, Masahiro Kizaki, Naoya Sekiguchi, Chen Kang Chien, Reiko Watanabe, Tomoe Nemoto

Publikováno v: International Journal of Hematology. 87:520-526

We here report the case of a young Japanese woman diagnosed with chronic active Epstein-Barr virus (EBV) infection. Intensive therapy with the CHOP regimen was partially able to control virus expansion, but various central nervous system symptoms app

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4bd49b129dbfdc3551ed11ae5f4527a2
https://doi.org/10.1007/s12185-008-0069-4

Zobrazit plný text záznamu

Factors predicting the response to low-dose methotrexate therapy in patients with rheumatoid arthritis: a better response in male patients

Autor: Koichi Amano, Hiroe Ogawa, Hideto Kameda, Hirofumi Takei, Naoya Sekiguchi, Tsutomu Takeuchi, Hayato Nagasawa

Publikováno v: Modern rheumatology. 14(6)

Methotrexate (MTX) is the most commonly used disease-modifying antirheumatic drug (DMARD) throughout the world. In Japan, MTX is recommended by the Japanese Ministry of Health, Labour, and Welfare to be given as the second or third DMARD and at a dos

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed96157377bdc67b1417ee315a44a9cb
https://pubmed.ncbi.nlm.nih.gov/24387720

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání